Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
CGF membranes will be prepared using a swing-lock centrifuge. A full-thickness mucoperiosteal flap will be elevated in a narrow alveolar ridge. Implants will be inserted. Autologous bone chips will be harvested via bone scraping and used for augmentation, CGF membranes will be placed over the grafted area. Suturing of the mucoperiosteal flap. Radiographic evaluation of the bone density and tissue thickness will be performed by CBCT preoperatively, immediate postoperative and after the procedure by 4 months. Clinical evaluation of the tissue thickness using periodontal probe preoperatively, immediate postoperatively and after the procedure by 4 months
Sterile drapes will be placed to minimize contamination.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| GTR with Autogenous Bone Chips and CGF Membrane | Other |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| concentrated growth factor (CGF) Membrane | Other | This is a third-generation autologous blood concentrate prepared using a dedicated centrifuge system. The process creates a fibrin-rich organic matrix from the patient's own blood, which is then molded into a membrane and packed over the grafted bone to enhance bone density increase and improvement of the surrounding tissue. |
| Measure | Description | Time Frame |
|---|---|---|
| tissue biotype | using periodontal probe to measure gingival thickness | preoperative, immediate postoperative and 4 months after the procedure |
| Measure | Description | Time Frame |
|---|---|---|
| bone density | cbct xray | preoperative, immediately postoperative, and 4 months after the surgery |
| patient satisfaction | psq18 is a chart where the patient describes the level of their satisfaction |
Not provided
inclusion criteria:
exclusion criteria: A medical history that contraindicates oral surgical treatment such as (uncontrolled/untreated diabetes mellitus, immuno-compromised status, radio or chemotherapy of the oral and maxillofacial region, treatment with oral and/or intravenous bisphosphonates).
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| meis youssef moustafa, bachelors | Contact | 00201065186643 | 00201065186643 | meis.eltanany@dentistry.cu.edu.eg |
| Name | Affiliation | Role |
|---|---|---|
| Hesham Elsayed Elhawary, Professor | Cairo University | Study Chair |
| Abdelmoez Mohamed El-Sharkawy, Assistant Professor | Cairo University | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cairo University | Giza | Cairo Governorate | 12511 | Egypt |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D016301 | Alveolar Bone Loss |
| ID | Term |
|---|---|
| D001862 | Bone Resorption |
| D001847 | Bone Diseases |
| D009140 | Musculoskeletal Diseases |
| D055093 | Periodontal Atrophy |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| after 4 months from the surgery |
| D010510 |
| Periodontal Diseases |
| D009059 | Mouth Diseases |
| D009057 | Stomatognathic Diseases |